Amatheon Agri Receives Regulatory Approval to Cultivate Medical Cannabis in Zimbabwe

This is the first and important regulatory step and allows the Company to enter a detailed planning phase whereby it will identify the site, variety and protocols required for production.

US market research company BDSA estimated a global market size of US$ 21.3 billion for 2020, with expected global sales of US$ 55.9 billion in 2026.

Among patients and healthcare professionals, there is an increasing awareness about the benefits of medical cannabis for a variety of ailments.

The license has been awarded for five years with an option to renew, and the entire project will be subject to strict controls and compliance regulations.

“This approval lays the foundation for Amatheon Agri’s entry into a highly lucrative future industry,” says Founder and CEO of Amatheon Agri Holding N.V., Mr. Carl Heinrich Bruhn.

“Its variety of landscapes, ideal climatic conditions, abundant water supply, long hours of sunlight and talented labor market makes the country well poised for our new investment,” he says.

In line with this strategy, the Company is now focusing on the large-scale cultivation of spices, in particular Birds Eye Chillies and Cayenne Peppers.

Amatheon guarantees offtake through a contract farming agreement, whereby the farmers receive a fixed buying price pegged to the US Dollar and then markets the products regionally and internationally.

With a combination of international distribution network, incorporated local know-how as well as a sustainable vision for the future, Amatheon Agri has been able to establish itself as a strategically aligned global player in the African agricultural sector.

The United States and Europe are closing in on a deal to end a 17-year-old dispute over aircraft subsidies and end tariffs, while seeking an elusive consensus on how to address competition from China, people familiar with the matter said on Monday.

this year as they try to keep their stake in the world’s biggest retailer from ballooning amid the company’s stock buybacks.The Walton Family Holdings Trust sold $430 million worth over the past week, taking their total sales to almost $2.1 billion since Jan.

— The world’s top makers of Covid-19 vaccines dropped after tests of Novavax Inc.’s shots showed they were 90% effective at preventing symptoms.Stocks tied to inoculations already cleared for emergency use fell in Monday trading, led by Moderna Inc closed down 5.2% after dropping 9.5% intraday.

In Europe, the STOXX 600 index rose 0.15% after hitting record highs, lifted by the prospect of a broadening economic recovery from COVID-19 and anticipation of dovish monetary policy from central banks.

— Saks, newly minted as a standalone e-commerce business that’s separate from the Saks Fifth Avenue department stores, is adding NBA star James Harden to its board.Harden, who plays for the Brooklyn Nets and has led the league in scoring three times, is also making a minority investment in Saks.

— Shares of companies controlled by billionaire Gautam Adani recouped a part of their day’s losses after refuting a local report that said accounts of three Mauritius-based funds that own the group’s stocks were frozen.The Economic Times reported Monday that National Securities Depository Ltd.

Chief Executive Officer Jamie Dimon signaling a 38% decline in trading revenue from a year ago — a bigger drop than previously expected.Trading revenue at the largest U.S.

— Many of the issues thrown up in the transition away from sterling Libor appear to have been addressed, Bank of England Governor Andrew Bailey said Monday, delivering a confident assessment of the U.K.’s exit from the discredited benchmark.Britain, the home of Libor, is making faster progress than the U.S.

Meng, 49, was arrested at Vancouver International Airport in December 2018 on a warrant from the United States, where she faces charges of bank fraud for allegedly misleading HSBC about Huawei Technologies Co Ltd’s business dealings in Iran and potentially causing the bank to break U.S.

…Read the full story